What this deck covers
This deck focuses on Pca Safety And Monitoring, giving you a quick way to review the definitions, rules, and examples that matter most for Nclexrn.
Study Pca Safety And Monitoring in Nclexrn with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What is the PCA "basal rate" setting?
Tap card or press Space to flip
Continuous background opioid infusion. A basal rate provides a steady low-dose opioid delivery to maintain analgesia, supplementing patient-initiated boluses.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Pca Safety And Monitoring, giving you a quick way to review the definitions, rules, and examples that matter most for Nclexrn.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Continuous background opioid infusion. A basal rate provides a steady low-dose opioid delivery to maintain analgesia, supplementing patient-initiated boluses.
Answer: Opioid-naïve status. Opioid-naïve patients lack tolerance, making them more susceptible to respiratory depression from continuous basal infusions.
Answer: Baseline pain, sedation, and respiratory assessment. Establishing pre-treatment baselines allows for accurate detection of opioid-related changes in pain control, alertness, and respiratory function.
Answer: The patient (no family or staff "PCA by proxy"). Only the patient should activate the device to ensure dosing aligns with their alertness level, preventing inadvertent overdose from others.
Answer: Secure controlled substance; do not leave extra doses accessible. Proper security of opioids prevents diversion or tampering, complying with controlled substance regulations and maintaining patient safety.
Answer: Decreased RR. Opioids cause respiratory depression, whereas uncontrolled pain typically elevates blood pressure through sympathetic activation.
Answer: RR 6/min. A respiratory rate of 6/min signals severe hypoventilation requiring reversal, whereas high pain scores indicate inadequate analgesia without immediate danger.
Answer: Obstructive sleep apnea. Obstructive sleep apnea predisposes patients to airway obstruction, exacerbating opioid-induced respiratory depression and necessitating vigilant monitoring.
Answer: Demands and deliveries, plus pain, sedation, and respirations. Documenting attempts versus successful doses alongside clinical trends ensures evaluation of PCA efficacy and early detection of adverse effects.
Answer: Benzodiazepines or other CNS depressants. These medications potentiate opioid effects on the central nervous system, heightening the risk of profound sedation and respiratory compromise.
Answer: Naloxone. As an opioid antagonist, naloxone competitively binds to mu-receptors, rapidly reversing overdose effects like respiratory depression.
Answer: Independent double-check by two licensed nurses. Double-checking minimizes programming errors with high-alert opioids, enhancing patient safety during PCA administration.
Answer: Capnography (end-tidal CO2 monitoring). Capnography measures exhaled carbon dioxide levels, identifying hypoventilation sooner than pulse oximetry, which may remain normal until severe hypoxia develops.
Answer: Stop/hold opioid, stimulate, and assess airway/respirations. Immediate cessation of opioid delivery and patient stimulation are critical to restore consciousness and evaluate for respiratory depression.
Answer: Repeat dosing within a set time to limit overdose risk. The lockout interval enforces a minimum time between doses, safeguarding against excessive opioid accumulation and resultant toxicity.
Answer: "My spouse can press it while I sleep.". This statement promotes PCA by proxy, which circumvents safety features and risks oversedation since the patient may not be alert enough to self-dose.
Answer: PCA by proxy. This term describes unauthorized activation by non-patients, which bypasses the safety mechanism of patient-controlled dosing and increases overdose risk.
Answer: Self-titration reduces oversedation risk when used correctly. Patient self-administration allows for precise dosing based on real-time pain needs, minimizing the risk of excessive opioid accumulation from delayed nurse responses.
Answer: Decreased respiratory rate. Opioids primarily depress the respiratory center, making bradypnea an early indicator of potential life-threatening hypoventilation.
Answer: Post-op patient with obstructive sleep apnea. Postoperative patients with OSA face compounded risks of respiratory depression from opioids and airway obstruction, demanding continuous oversight.
Answer: Dedicated line (avoid piggybacking into PCA line). A dedicated line prevents drug incompatibilities and accidental boluses from other infusions, ensuring safe PCA delivery.
Answer: Sedation level. Trending sedation provides earlier detection of opioid-induced central nervous system depression compared to pain scores, which may not correlate with safety risks.
Answer: Press the button at onset of pain; do not wait until severe. Early activation maintains steady analgesia levels, preventing pain escalation that requires higher doses and increases side effect risks.
Answer: Patient-controlled analgesia. PCA enables patients to self-administer analgesics intravenously within prescribed limits for effective pain control.
Answer: Assess IV site and tubing patency; do not override blindly. Assessing for occlusions ensures resolution of mechanical issues without risking unsafe overrides that could lead to dosing errors.